Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats

Brain Research

Volumn 954, Issue 1, 2002, Pages 132-140

  Lu, Lin ^a,b,d   Zhang, Ben ^a   Liu, Zhiyuan ^b   Zhang, Zhanyin ^c  

^a SHANDONG MENTAL HEALTH CENTER   (China)

^b SICHUAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Stress

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ RECEPTOR; COCAINE; DEVAZEPIDE; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SHOCK; STRESS;

ANIMALS; BENZODIAZEPINONES; BRAIN; COCAINE; CONDITIONING, OPERANT; DEVAZEPIDE; HORMONE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; MALE; PHENYLUREA COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; STRESS;

EID: 0036838507     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03359-0     Document Type: Article

References (60)

1. Becker C., Thiebot M.H., Touitou Y., Hamon M., Cesselin F., Benoliel J.J. Enhanced cortical extracellular levels of cholecystokinin-like material in a model of anticipation of social defeat in the rat. J. Neurosci. 21:2001;262-269.
2. Bourin M., Malinge M., Vasar E., Bradwejn J. Two faces of cholecystokinin: anxiety and schizophrenia. Fund. Clin. Pharmacol. 10:1996;116-126.
3. Bradwejn J., Koszycki D., Couetoux du Tertre A., van Megen H., den Boer J., Westenberg H. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch. Gen. Psychiatry. 51:1994;486-493.
4. Cabib S., Puglisi-Allegra S. Stress, depression and the mesolimbic dopamine system. Psychopharmacology. 128:1996;331-342.
5. Crespi F., Corsi M., Reggiani A., Ratti E., Gaviraghi G. Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands. Expert. Opin. Invest. Drugs. 9:2000;2249-2258.
6. Crespi F. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonist in the spontaneous preference for drug of abuse (alcohol or cocaine) in naïve rats. Meth. Find. Exp. Clin. Pharmacol. 20:1998;679-697.
7. Del Bel E.A., Guimaraes F.S. Social isolation increases cholecystokinin mRNA in the central nervous system of rats. NeuroReport. 8:1997;3597-3600.
8. Deroche V., Piazza P.V., Casolini P., Maccari S., Le Moal M., Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion. Brain Res. 598:1992;343-348.
9. DeSousa N.J., Wunderlich G.R., De Cabo C., Vaccarino F.J. The expression of behavioral sensitization to amphetamine: role of CCK (A) receptors. Pharmacol. Biochem. Behav. 62:1999;31-37.
10. Dunlop J. CCK receptor antagonists. Gen. Pharmacol. 31:1998;519-524.
11. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress-and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 18:1998;5529-5536.
12. Higgins G.A., Nguyen P., Sellers E.M. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists. Brain Res. 572:1992;208-215.
13. Highfield D., Clements A., Shaley U., McDonald R., Featherstone R., Stewart J., Shaham Y. Involvement of the medial septum in stress-induced relapse to heroin seeking in rats. Eur. J. Neurosci. 12:2000;1705-1713.
14. Hill D.R., Campbell N.J., Shaw T.M., Woodruff G.N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neurosci. 7:1987;2967-2976.
15. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in mesolimbic neurons. Nature. 285:1980;476-478.
16. Hommer D.W., Stoner G., Crawley J.N., Paul S.M., Skirboll L.R. Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype. J. Neurosci. 6:1986;3039-3043.
17. Honda T., Wada E., Battery J.F., Wank S.A. Differential gene expression of CCKA and CCKB receptors in the rat brain. Mol. Cell. Neurosci. 4:1993;143-154.
18. Jones B., Mishkin M. Limbic lesions and the problem of stimulus - reinforcement associations. Exp. Neurol. 36:1972;362-377.
19. Josselyn S.A., De Cristofaro A., Vaccarino F.J. Evidence for CCK (A) receptor involvement in the acquisition of conditioned activity produced by cocaine in rats. Brain Res. 763:1997;93-102.
20. Josselyn S.A., Vaccarino F.J. Acquisition of conditioned reward blocked by intra-accumbens infusion of PD-140548, a CCKA receptor antagonist. Pharmacol. Biochem. Behav. 55:1996;439-444.
21. Koob G.F. Stress, corticotropin-releasing factor, and drug addiction. Ann. NY Acad. Sci. 897:1999;27-45.
22. Kruzich P.J., See R.E. Differential contributions of the basolateral and central amygdala in the acquisition and expression of conditioned relapse to cocaine-seeking behavior. J. Neurosci. 21:2001;RC155.
23. Ladurelle N., Roques B.P., Dauge V. The transfer of rats from a familiar to a novel environment prolongs the increase of extracellular dopamine efflux induced by CCK8 in the posterior nucleus accumbens. J. Neurosci. 15:1995;3118-3127.
24. Lambert M., Bui N.D., Christophe J. Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR4-2J. Regul. Pep. 322:1991;151-167.
25. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediates autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8:1988;2517-2529.
26. Lu L., Huang M., Liu Z., Ma L. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. NeuroReport. 11:2000;829-832.
27. Lu L., Huang M., Ma L., Li J. Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats. Behav. Brain Res. 120:2001;105-110.
28. Lu L., Liu D., Ceng X., Ma L. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence. Eur. J. Neurosci. 12:2000;4398-4404.
29. Lu L., Xu N.J., Ge X., Yue W., Su W.J., Pei G., Ma L. Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology. 159:2002;125-132.
30. McGaugh J.L., Cahill L. Interaction of neuromodulatory systems in modulating memory storage. Behav. Brain Res. 83:1997;31-38.
31. Mitchell J.M., Basbaum A.I., Fields H.L. A locus and mechanism of action for associative morphine tolerance. Nat. Neurosci. 3:2000;47-53.
32. Mutt V., Jorpes J.E. Structure of porcine cholecystokinin-pancreozymin. 1. Cleavage with thrombin and with trypsin. Eur. J. Biochem. 6:1968;156-162.
33. Myrick H., Brady K.T., Malcolm R. New developments in the pharmacotherapy of alcohol dependence. Am. J. Addict. 10:(Suppl):2001;3-15.
34. Nagata A., Ito M., Iwata N., Kuno J., Takano H., Minowa O., Chihara K., Matsui T., Noda T. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;11825-11830.
35. 125I-Bolton-Hunter CCK8. Peptides. 10:1989;265-274.
36. Noble F., Rogues B.P. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog. Neurobiol. 58:1999;349-379.
37. 125I]Bolton-Hunter CCK8: functional significance of subregional distributions. Neurochem. Int. 10:1987;495-508.
38. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons. Annu. Rev. Pharmacol. 36:1996;359-378.
39. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216.
40. Pohl M., Collin E., Benoliel J.J., Bourgoin S., Cesselin F., Hamon M. Cholecystikinin-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment. Neuropeptides. 21:1992;193-200.
41. Rehfeld J.F., Holst J.J., Jensen S.L. The molecular nature of vasularly released cholecystokinin from the isolated perfused porcine duodenum. Regul. Pept. 3:1982;15-28.
42. Roques B.P., Noble F. Association of enkephalin catabolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction. Neurochem. Res. 21:1996;1397-1410.
43. Roques B.P. Novel approaches to targeting neuropeptide systems. Trends Pharmacol. Sci. 21:2000;475-483.
44. Satel S.L., Price L.H., Palumbo J.M., McDougle C.J., Krystal J.H., Gawin F., Charney D.S., Heninger G.R., Kleber H.D. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am. J. Psychiatry. 148:1991;1712-1716.
45. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Rev. 33:2000;13-33.
46. Shalev U., Grimm J.W., Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol. Rev. 54:2002;1-42.
47. Sinha R., Fuse T., Aubin L.R., O'Malley S.S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology. 52:2000;140-148.
48. Sinha R., Catapano D., O'Malley S.S. Stress-induced craving and stress response in cocaine dependent individuals. Psychopharmacology. 142:1999;343-351.
49. Spiegler B.J., Mishkin M. Evidence for the sequential participation of inferior temporal cortex and amygdala in the acquisition of stimulus-reward associations. Behav. Brain Res. 3:1981;303-317.
50. Stanfa L., Dickenson A., Xu X.J., Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol. Sci. 15:1994;65-66.
51. Stewart J. Pathways to relapse: the neurobiology of drug- and stress-induced relapse to drug-taking. J. Psychiatry Neurosci. 25:2000;125-136.
52. Tanganelli S., Fuxe K., Antonelli T., O'Connor W.T., Ferraro L. Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: biochemical and functional correlates. Peptides. 22:2001;1229-1234.
53. Tsutsumi T., Akiyoshi J., Isogawa K., Kohno Y., Hikichi T., Nagayama H. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158. Neuropeptides. 33:1999;483-486.
54. Vaccarino F.J., Vaccarino A.L. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward. Neurosci. Lett. 97:1989;151-156.
55. Valverde O., Blommaert A.G.S., Fournie-Zaluski M.C., Roques B.P., Maldonado R. Weak tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCK-B antagonist. Eur. J. Pharmacol. 286:1995;79-93.
56. Verge V.M., Wiesenfeld-Hallin Z., Hokfelt T. Cholecystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies on rat and monkey. Eur. J. Neurosci. 5:1993;240-250.
57. Wang R.Y. Cholecystokinin, dopamine, and schizophrenia: recent progress and current problems. Ann. NY Acad. Sci. 537:1988;362-379.
58. Wang X., Cen X., Lu L. Noradrenaline in the bed nucleus of the stria terminalis is critical for stress-induced reactivation of morphine-conditioned place preference in rats. Eur. J. Pharmacol. 432:2001;153-161.
59. Wunderlich G.R., DeSousa N.J., Vaccarino F.J. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat. Psychopharmacology. 151:2000;283-290.
60. Yadid G., Overstreet D.H., Zangen A. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression. Brain Res. 896:2001;43-47.